Similar articles

• Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study.

  Leibovici L, Paul M, Poznanski O, Drucker M, Samra Z, Konigsberger H, Pitlik SD. Leibovici L, et al. Antimicrob Agents Chemother. 1997 May;41(5):1127-33. doi: 10.1128/AAC.41.5.1127. Antimicrob Agents Chemother. 1997. PMID: 9145881 Free PMC article.
• Aminoglycosides versus beta-lactams in gram-negative pneumonia.

  Collins T, Gerding DN. Collins T, et al. Semin Respir Infect. 1991 Sep;6(3):136-46. Semin Respir Infect. 1991. PMID: 1754734 Review.
• Is there evidence on the optimal duration of aminoglycoside therapy in β-lactam/aminoglycoside combination regimens used for the treatment of gram-negative bacterial infections? A systematic review.

  Wale YM, Roberts JA, Wolie ZT, Sime FB. Wale YM, et al. Int J Antimicrob Agents. 2024 Oct;64(4):107297. doi: 10.1016/j.ijantimicag.2024.107297. Epub 2024 Aug 5. Int J Antimicrob Agents. 2024. PMID: 39111709
• The Effect of a Single-Dose Aminoglycoside With a Beta-Lactam for the Treatment of Gram-Negative Bacteremia.

  Cerenzio J, Andrade J, DeAngelis J, Truong J. Cerenzio J, et al. J Pharm Pract. 2025 Feb;38(1):141-148. doi: 10.1177/08971900241273212. Epub 2024 Aug 26. J Pharm Pract. 2025. PMID: 39185751
• Empiric combination therapy for gram-negative bacteremia.

  Sick AC, Tschudin-Sutter S, Turnbull AE, Weissman SJ, Tamma PD. Sick AC, et al. Pediatrics. 2014 May;133(5):e1148-55. doi: 10.1542/peds.2013-3363. Epub 2014 Apr 7. Pediatrics. 2014. PMID: 24709936